<SEC-DOCUMENT>0001193125-21-141263-index.html : 20210429
<SEC-HEADER>0001193125-21-141263.hdr.sgml : 20210429
<ACCEPTANCE-DATETIME>20210429181724
ACCESSION NUMBER:		0001193125-21-141263
CONFORMED SUBMISSION TYPE:	S-1MEF
PUBLIC DOCUMENT COUNT:		6
<REFERENCE-462B>333-255132
FILED AS OF DATE:		20210429
DATE AS OF CHANGE:		20210429
EFFECTIVENESS DATE:		20210429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Werewolf Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001785530
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				823523180
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1MEF
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-255627
		FILM NUMBER:		21872670

	BUSINESS ADDRESS:	
		STREET 1:		1030 MASSACHUSETTS AVENUE
		STREET 2:		SUITE 210
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02138
		BUSINESS PHONE:		617-952-0555

	MAIL ADDRESS:	
		STREET 1:		1030 MASSACHUSETTS AVENUE
		STREET 2:		SUITE 210
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02138
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1MEF
<SEQUENCE>1
<FILENAME>d160351ds1mef.htm
<DESCRIPTION>S-1MEF
<TEXT>
Document 1 - file: d160351ds1mef.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d160351dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d160351dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d160351dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: d160351dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g160351dsp05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g160351dsp05.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g160351dsp05a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g160351dsp05a.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g160351dsp05b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g160351dsp05b.jpg

</DOCUMENT>
</SEC-DOCUMENT>